{
  "created_at": "Tue Oct 05 13:3:40 +0000 2021",
  "id_str": "1445335496138313733",
  "full_text": "AstraZeneca asked U.S. regulators for emergency-use authorization for an antibody drug that earlier this year showed strong efficacy in preventing symptomatic Covid-19, offering a potential alternative in evading the disease https://t.co/Y4WhFIap9a",
  "display_text_range": [
    0,
    248
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/Y4WhFIap9a",
        "expanded_url": "https://on.wsj.com/2ZOoapK",
        "display_url": "on.wsj.com/2ZOoapK",
        "indices": [
          225,
          248
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 30,
  "favorite_count": 91,
  "possibly_sensitive": false,
  "original_created_at": "Tue Oct 05 10:30:09 +0000 2021"
}